All News #Library
Biotech
Privo Technologies Acquires Medico Pharma In Strategic Move
23 Jan 2026 //
PR NEWSWIRE
Privo Begins Dosing PRV-131 in Arm 3 of CLN-004 Oral Cancer Trial
10 Dec 2025 //
PR NEWSWIRE
PRV111, Meets Primary Efficacy Endpoint In Phase 2/3 Trial
17 Nov 2025 //
PR NEWSWIRE

Market Place
Sourcing Support